A twice-yearly HIV prevention jab will be available at low cost in 120 lower income countries beginning in 2027. The drug, known as lenacapavir, has been hailed as a medical breakthrough that could change the trajectory of the global HIV epidemic, wh... [3366 chars].. reed more
